You are here
Advanced Targeting Systems
UEI: Z8PDT5YVMP24
# of Employees: 9
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Enhancing CRISPR based Therapeutic Interventions Via a Targeted Platform Tool
Amount: $150,000.00Enhancing CRISPR based Therapeutic Interventions Via a Targeted Platform Tool Project Summary The approach described in this proposal anticipates the needs of translational drug development by design ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Targeting a Poor Prognosis Marker for Tumor Therapy
Amount: $150,480.00DESCRIPTION (provided by applicant): Targeting a Poor Prognosis Marker for Tumor Therapy Summary The purpose of this proposal is to develop a medical treatment for the elimination of metastatic ca ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Selective Activation in Specific Neuronal Populations
Amount: $99,175.00DESCRIPTION (provided by applicant): Selective Activation in Specific Neuronal Populations Summary: Molecules targeted towards cell surface markers have been used for years to identify specific cell t ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
Inhibition of Neurotransmission in Specific Neuronal Populations
Amount: $114,336.00DESCRIPTION (provided by applicant): In extensive work over the last decade, it has become clear that biologically active molecules can be inserted into specific cell types through targeting to molec ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Drug Development of a Chronic Pain Therapeutic
Amount: $0.00DESCRIPTION (provided by applicant): SP-SAP, a conjugate between the peptide neurotransmitter substance P, and the ribosome-inactivating protein, saporin, has been shown, through previous NIH funding, ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Drug Development of a Chronic Pain Therapeutic
Amount: $2,388,923.00DESCRIPTION (provided by applicant): SP-SAP, a conjugate between the peptide neurotransmitter substance P, and the ribosome-inactivating protein, saporin, has been shown, through previous NIH funding, ...
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
Monoclonal Antibodies to Target Neuronal Populations
Amount: $0.00N/A
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Monoclonal Antibodies to Target Neuronal Populations
Amount: $798,353.00N/A
SBIRPhase II2003Department of Health and Human Services National Institutes of Health -
Targeting Neurons Involved in Chronic Pain Transmission
Amount: $133,547.00DESCRIPTION (Adapted from applicant's abstract): Chronic pain is an enormous problem in the United States: it is estimated that 30 to 100 million people suffer from it. Often, current ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health -
TOXICOLOGY/SAFETY STUDIES OF A CHRONIC PAIN THERAPEUTIC
Amount: $397,984.00N/A
SBIRPhase II2001Department of Health and Human Services National Institutes of Health
